Oxygen therapy for infants with chronic lung disease.
Supplemental oxygen is a safe and effective treatment for infants with established chronic lung disease who are not at risk of further progression of retinopathy of prematurity (ROP). Oxygen saturations of < 92% should be avoided and a target range of at least 94-96% aimed for. The saturation target range for very preterm infants at risk of developing ROP is more controversial, but the therapeutic index is probably considerably narrower.
Kotecha
S
S
Department of Child Health, University of Leicester, Leicester LE2 7LX, UK. sk43@le.ac.uk
Allen
J
J
D002908:Chronic Disease; D003153:Community Health Services / Q000458:organization & administration; D003688:Deinstitutionalization; D006699:Home Care Services / Q000458:organization & administration; D006801:Humans; D000860:Hypoxia / Q000628:therapy; D007223:Infant; D007231:Infant, Newborn; D008171:Lung Diseases / Q000097:blood / Q000628:therapy*; D008991:Monitoring, Physiologic; D015337:Multicenter Studies as Topic; D010092:Oximetry / Q000295:instrumentation; D010100:Oxygen / Q000097:blood / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012121:Respiration, Artificial / Q000295:instrumentation; D012178:Retinopathy of Prematurity / Q000209:etiology; D012895:Sleep, REM / Q000502:physiology; D015300:Ventilator Weaning
D010100:Oxygen